It simultaneously decreases food intake through GLP 1 and GIP effects, improves metabolic efficiency through GIP activation, and increases energy expenditure through glucagon receptor stimulation
If trials read out in late 2025 or early 2026 and Eli Lilly files an NDA promptly, the earliest realistic approval window is late 2026, with 2027 being more likely for the obesity indication
Once activated, T lymphocytes secrete pro-inflammatory cytokines such as interferon- (IFN-), interleukin-2 (IL-2), and tumor necrosis factor- (TNF-), which drive tissue damage
Research consistently shows that the best medication is the one you'll actually take consistently." Ultimately, this comes down to an honest conversation with your health care provider about your goals and what you can manage
Rotation works best when it is specific
Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE, Deacon CF, Holst JJ, Foley JE